US 12,071,556 B2
Curable ink composition
Jean Elizabeth Marshall, Cambridge (GB); and Martin Thompson, Cambridge (GB)
Assigned to Domino Printing Sciences PLC, Cambridge (GB)
Appl. No. 17/437,378
Filed by Domino Printing Sciences Plc, Cambridge (GB)
PCT Filed Mar. 6, 2020, PCT No. PCT/EP2020/055969
§ 371(c)(1), (2) Date Sep. 8, 2021,
PCT Pub. No. WO2020/182640, PCT Pub. Date Sep. 17, 2020.
Claims priority of application No. 1903147 (GB), filed on Mar. 8, 2019.
Prior Publication US 2022/0145109 A1, May 12, 2022
Int. Cl. C09D 11/328 (2014.01); B41M 5/00 (2006.01); C09B 62/002 (2006.01); C09D 11/037 (2014.01); C09D 11/101 (2014.01); C09D 11/107 (2014.01)
CPC C09D 11/328 (2013.01) [B41M 5/0023 (2013.01); C09B 62/0025 (2013.01); C09D 11/037 (2013.01); C09D 11/101 (2013.01); C09D 11/107 (2013.01)] 18 Claims
OG exemplary drawing
 
1. A curable inkjet ink composition comprising a dye monomer, a carrier monomer and an initiator wherein
the dye monomer has a chromophore moiety that is covalently bonded to two or more polymerizable functional groups and the dye monomer is present at 1.0 wt % or more based on total weight of the ink composition; and
the carrier monomer has at least one polymerizable functional group and is present at 50 wt % or more based on total weight of the ink composition.